Independent health-science reporting · Evidence ratedEvidence rated
Section
Reporting on how cancer care is changing: new therapeutic classes, resistance biology, combination strategies, and the practical distance between a promising result and a treatment a patient can actually receive.
A study tracking 25 years of publication data maps how the clinical and academic focus has transitioned toward neoadjuvant and combination strategies.
An alkaloid isolated from Stephania venosa halts cancer cell proliferation and triggers programmed cell death in vitro.
A study using spatial transcriptomics and machine learning highlights the role of SERPINE1 in tumor stromal remodeling.
By joining the ends of the RNA strand into a loop, researchers are evaluating circular RNA to resist degradation and extend protein expression in cancer applications.
Researchers have designed a biodegradable nanoparticle that combines chemotherapy, heat, and immunotherapy to target resistant solid tumors.
